249 filings
Page 7 of 13
4
Venkatesan Jay
25 May 22
Angion Biomedica / Jay Venkatesan ownership change
5:58pm
424B5
ELTX
Elicio Therapeutics Inc.
24 May 22
Prospectus supplement for primary offering
4:02pm
424B3
ELTX
Elicio Therapeutics Inc.
24 May 22
Prospectus supplement
4:01pm
EFFECT
ELTX
Elicio Therapeutics Inc.
24 May 22
Notice of effectiveness
12:15am
4
Allen Nissenson
23 May 22
Angion Biomedica / Allen Nissenson ownership change
7:48pm
SC 13G
Satterfield Thomas A JR
19 May 22
Angion Biomedica / SATTERFIELD THOMAS A JR ownership change
10:04am
CORRESP
ELTX
Elicio Therapeutics Inc.
19 May 22
Correspondence with SEC
12:00am
UPLOAD
ELTX
Elicio Therapeutics Inc.
19 May 22
Letter from SEC
12:00am
S-8
ELTX
Elicio Therapeutics Inc.
16 May 22
Registration of securities for employees
5:26pm
S-3
ELTX
Elicio Therapeutics Inc.
16 May 22
Shelf registration
5:23pm
8-K
ELTX
Elicio Therapeutics Inc.
16 May 22
Angion Provides Corporate Update and Reports First Quarter 2022 Financial Results
12:00am
10-Q
2022 Q1
ELTX
Elicio Therapeutics Inc.
Quarterly report
16 May 22
12:00am
SC 13G
ELTX
Elicio Therapeutics Inc.
27 Apr 22
Angion Biomedica / Angion Biomedica ownership change
4:10pm
SC 13D
ELTX
Elicio Therapeutics Inc.
27 Apr 22
Angion Biomedica / Angion Biomedica ownership change
4:08pm
DEFA14A
ELTX
Elicio Therapeutics Inc.
27 Apr 22
Additional proxy soliciting materials
4:06pm
DEF 14A
ELTX
Elicio Therapeutics Inc.
27 Apr 22
Definitive proxy
4:04pm
10-K
2021 FY
ELTX
Elicio Therapeutics Inc.
Annual report
30 Mar 22
4:56pm
8-K
ELTX
Elicio Therapeutics Inc.
30 Mar 22
Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
4:52pm
SC 13G
Vifor
30 Mar 22
Angion Biomedica / Vifor ownership change
3:51pm
4
Venkatesan Jay
4 Mar 22
Angion Biomedica / Jay Venkatesan ownership change
4:22pm